[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]

November 2017 - July 1883

Decade

Year

Issue

May 9, 2017, Vol 317, No. 18, Pages 1815-1920

In This Issue of JAMA

Highlights

Abstract Full Text
free access has audio
JAMA. 2017;317(18):1815-1817. doi:10.1001/jama.2016.13119
Viewpoint

Toward Responsible Human Genome Editing

Abstract Full Text
JAMA. 2017;317(18):1829-1830. doi:10.1001/jama.2017.4548

This Viewpoint discusses recommendations the US National Academies of Sciences and Medicine made in 2017 for the application and oversight of human genome editing in basic research, clinical disease, and germline cells.

Genomics, Health Disparities, and Missed Opportunities for the Nation’s Research Agenda

Abstract Full Text
JAMA. 2017;317(18):1831-1832. doi:10.1001/jama.2017.3096

This Viewpoint discusses the complexities of the health disparities in the United States and argues for better integration of genomic basis for understanding health disparities with social models of disease and disparities.

A Piece of My Mind

Medical Education and the Minority Tax

Abstract Full Text
JAMA. 2017;317(18):1833-1834. doi:10.1001/jama.2017.0196
Editorial

Treatment of KRAS-Mutant Non–Small Cell Lung CancerThe End of the Beginning for Targeted Therapies

Abstract Full Text
JAMA. 2017;317(18):1835-1837. doi:10.1001/jama.2017.3436

Worldwide Preparedness for Kidney Health Care

Abstract Full Text
JAMA. 2017;317(18):1838-1839. doi:10.1001/jama.2017.2825

How to Look for Thyroid Cancer

Abstract Full Text
JAMA. 2017;317(18):1840-1841. doi:10.1001/jama.2017.4068

Genomics and Precision Health

Introducing “Genomics and Precision Health”

Abstract Full Text
free access has multimedia has audio
JAMA. 2017;317(18):1842-1843. doi:10.1001/jama.2016.20625
Original Investigation

Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung CancerThe SELECT-1 Randomized Clinical Trial

Abstract Full Text
free access has active quiz
JAMA. 2017;317(18):1844-1853. doi:10.1001/jama.2017.3438

This randomized clinical trial compares the effects of survival of the MEK inhibitor selumetinib plus docetaxel vs docetaxel alone as second-line therapy for advanced KRAS-mutant non–small cell lung cancer.

Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010

Abstract Full Text
free access
JAMA. 2017;317(18):1854-1863. doi:10.1001/jama.2017.5150

This study describes withdrawals, boxed warnings, and safety communications affecting pharmaceuticals and biologics approved by the US Food and Drug Administration between 2001 and 2010, and associations between characteristics known at the time of approval and those events.

Assessment of Global Kidney Health Care Status

Abstract Full Text
free access
JAMA. 2017;317(18):1864-1881. doi:10.1001/jama.2017.4046

This study surveyed international nephrology society leaders, policy makers, and patient representatives to assess regional resources and ability to care for patients with kidney disease.

US Preventive Services Task Force

Recommendation Statement

Screening for Thyroid CancerUS Preventive Services Task Force Recommendation Statement

Abstract Full Text
free access has active quiz has audio
JAMA. 2017;317(18):1882-1887. doi:10.1001/jama.2017.4011

This Recommendation Statement from the US Preventive Services Task Force recommends against screening for thyroid cancer in asymptomatic adults (D recommendation).

Evidence Report

Screening for Thyroid CancerUpdated Evidence Report and Systematic Review for the US Preventive Services Task Force

Abstract Full Text
free access
JAMA. 2017;317(18):1888-1903. doi:10.1001/jama.2017.0562

This Evidence Report to support the 2017 update of the US Preventive Services Task Force Recommendation Statement on screening for thyroid cancer summarizes evidence about the benefits and harms associated with thyroid cancer screening and treatment of early thyroid cancer in asymptomatic adults.

JAMA Insights

Genomics and Precision Health

Finding the Rare Pathogenic Variants in a Human Genome

Abstract Full Text
has active quiz has audio
JAMA. 2017;317(18):1904-1905. doi:10.1001/jama.2017.0432

This Genomics and Precision Health essay discusses the risks and potential benefits of performing genome sequencing in healthy people.

Research Letter

Association Between Long-term Quinine Exposure and All-Cause Mortality

Abstract Full Text
free access
JAMA. 2017;317(18):1907-1909. doi:10.1001/jama.2017.2332

This cohort study uses UK primary care database data to explore the association between long-term quinine exposure and all-cause mortality.

Comment & Response

Use of the qSOFA Score in the Emergency Department

Abstract Full Text
JAMA. 2017;317(18):1909-1910. doi:10.1001/jama.2017.3504

Use of the qSOFA Score in the Emergency Department—Reply

Abstract Full Text
JAMA. 2017;317(18):1910. doi:10.1001/jama.2017.3511

Outlier in Analysis of Cancer Mortality by US County

Abstract Full Text
JAMA. 2017;317(18):1910-1911. doi:10.1001/jama.2017.4128

Outlier in Analysis of Cancer Mortality by US County—Reply

Abstract Full Text
JAMA. 2017;317(18):1911. doi:10.1001/jama.2017.4132

Legal Complexities of Global Vaccine Compensation Systems

Abstract Full Text
JAMA. 2017;317(18):1911-1912. doi:10.1001/jama.2017.4423

Legal Complexities of Global Vaccine Compensation Systems—Reply

Abstract Full Text
JAMA. 2017;317(18):1912. doi:10.1001/jama.2017.4432
Correction

Incorrect Unit of Measure

Abstract Full Text
free access
JAMA. 2017;317(18):1912. doi:10.1001/jama.2017.4657

Misspelling of Author Name

Abstract Full Text
free access
JAMA. 2017;317(18):1912. doi:10.1001/jama.2017.4662

Incorrect Funder

Abstract Full Text
free access
JAMA. 2017;317(18):1912. doi:10.1001/jama.2017.4857
Medical News & Perspectives

Farewell to a Cancer That Never Was

Abstract Full Text
JAMA. 2017;317(18):1824-1825. doi:10.1001/jama.2017.3969

This Medical News story follows up on the recent downgrading of a form of thyroid cancer to a noncancerous neoplasm.

Capitol Health Call

Investigation Into Opioid Crisis Targets Drug Companies

Abstract Full Text
JAMA. 2017;317(18):1826. doi:10.1001/jama.2017.5130

Hearing Focuses on Proposed Cuts in Cancer Research

Abstract Full Text
JAMA. 2017;317(18):1826. doi:10.1001/jama.2017.5383

Maker of Duodenoscopes Under Scrutiny Again

Abstract Full Text
JAMA. 2017;317(18):1826. doi:10.1001/jama.2017.5385
News From the Centers for Disease Control and Prevention

How Much Do You Drink?

Abstract Full Text
JAMA. 2017;317(18):1827. doi:10.1001/jama.2017.4666

Medicaid’s Impact on Overdose Rates

Abstract Full Text
JAMA. 2017;317(18):1827. doi:10.1001/jama.2017.5101
The Arts and Medicine

The Center Cannot HoldMedicine, Music, and the Mind

Abstract Full Text
has multimedia
JAMA. 2017;317(18):1822-1823. doi:10.1001/jama.2017.4690

This Arts and Medicine essay reviews the 2-act chamber opera The Center Cannot Hold, which tells the story of Elyn Saks, who developed schizophrenia in childhood but went on to become a law professor and mental health advocate.

Poetry and Medicine

Everywhen*

Abstract Full Text
JAMA. 2017;317(18):1913. doi:10.1001/jama.2017.0008
JAMA Revisited

Medicolegal

Abstract Full Text
JAMA. 2017;317(18):1914. doi:10.1001/jama.2017.0648
JAMA Patient Page

Screening for Thyroid Cancer

Abstract Full Text
free access
JAMA. 2017;317(18):1920. doi:10.1001/jama.2017.5254
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2017;317(18):1819-1820. doi:10.1001/jama.2016.13120
×